MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F4 (formerly 1F4)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7F3 (formerly 7F3)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI8H1 (formerly 8H1)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI5F5 (formerly 5F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Transient overexpression lysate of mitogen-activated protein kinase kinase 1 (MAP2K1)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of MAP2K1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Anti-MAP2K1 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAP2K1 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal Anti-MAP2K1 Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
Rabbit anti-MEK1 Polyclonal Antibody
| Applications | ELISA, ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
热销推荐
MEK1 (MAP2K1) pThr292 rabbit polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Pathways
- Acute myeloid leukemia (262)
- B cell receptor signaling pathway (262)
- Bladder cancer (262)
- Chemokine signaling pathway (262)
- Chronic myeloid leukemia (262)
- Colorectal cancer (262)
- Dorso-ventral axis formation (262)
- Endometrial cancer (262)
- ErbB signaling pathway (262)
- Fc epsilon RI signaling pathway (262)
- Fc gamma R-mediated phagocytosis (262)
- Focal adhesion (262)
- Gap junction (262)
- Glioma (262)
- GnRH signaling pathway (262)
- Insulin signaling pathway (262)
- Long-term depression (262)
- Long-term potentiation (262)
- MAPK signaling pathway (262)
- Melanogenesis (262)
- Melanoma (262)
- Natural killer cell mediated cytotoxicity (262)
- Neurotrophin signaling pathway (262)
- Non-small cell lung cancer (262)
- Oocyte meiosis (262)
- Pancreatic cancer (262)
- Pathways in cancer (262)
- Prion diseases (262)
- Progesterone-mediated oocyte maturation (262)
- Prostate cancer (262)
- Regulation of actin cytoskeleton (262)
- Renal cell carcinoma (262)
- T cell receptor signaling pathway (262)
- Thyroid cancer (262)
- Toll-like receptor signaling pathway (262)
- VEGF signaling pathway (262)
- Vascular smooth muscle contraction (262)
